NewEdge Advisors LLC Purchases 8,373 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• NewEdge Advisors LLC increased its stake in Intuitive Surgical, Inc. by 67.3%, acquiring an additional 8,373 shares, bringing their total holdings to 20,815 shares valued at approximately $10.3 million.
• Insider transactions included EVP Myriam Curet selling 4,500 shares and Director Amy L. Ladd selling 336 shares, indicating significant decreases in their ownership percentages.
• Analysts have mixed views on ISRG, with Zacks Research downgrading it to "hold," while others like Wells Fargo raised their price target, suggesting a consensus rating of "Moderate Buy" with an average target price of $595.95.

NewEdge Advisors LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 67.3% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 20,815 shares of the medical equipment provider's stock after purchasing an additional 8,373 shares during the quarter. NewEdge Advisors LLC's holdings in Intuitive Surgical were worth $10,309,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in ISRG. Brighton Jones LLC boosted its position in Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after purchasing an additional 731 shares during the period. Bank Pictet & Cie Europe AG boosted its position in Intuitive Surgical by 0.5% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock worth $99,678,000 after purchasing an additional 883 shares during the period. Cary Street Partners Financial LLC bought a new stake in Intuitive Surgical during the fourth quarter worth approximately $220,000. Driehaus Capital Management LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth about $601,000. Finally, Fiduciary Trust Co lifted its position in shares of Intuitive Surgical by 1.1% during the 4th quarter. Fiduciary Trust Co now owns 10,286 shares of the medical equipment provider's stock worth $5,369,000 after purchasing an additional 111 shares during the last quarter. Institutional investors own 83.64% of the company's stock.

Insider Activity at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,500 shares of the firm's stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Amy L. Ladd sold 336 shares of the firm's stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the completion of the sale, the director owned 1,074 shares of the company's stock, valued at approximately $504,898.14. This trade represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts recently weighed in on ISRG shares. Zacks Research cut Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, August 20th. Erste Group Bank reissued a "hold" rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Wells Fargo & Company increased their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a research report on Wednesday, July 23rd. Truist Financial increased their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a research report on Wednesday, July 23rd. Finally, UBS Group increased their price objective on Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a research report on Wednesday, July 23rd. Thirteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $595.95.

Intuitive Surgical Trading Up 2.7%

Shares of NASDAQ ISRG opened at $466.86 on Friday. The business has a fifty day simple moving average of $494.00 and a 200 day simple moving average of $512.73. The firm has a market capitalization of $167.36 billion, a price-to-earnings ratio of 65.11, a PEG ratio of 4.89 and a beta of 1.61. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical's revenue was up 21.4% on a year-over-year basis. During the same period in the prior year, the company posted $1.78 earnings per share. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.